Prazepam (1.0 mg/mL in Methanol)

For research use only. Not for therapeutic Use.

  • CAT Number: R032414
  • CAS Number: 2955-38-6
  • Molecular Formula: C19H17ClN2O
  • Molecular Weight: 324.808
  • Purity: ≥95%
Inquiry Now

Prazepam is a benzodiazepine derivative drug developed by Warner-Lambert in the 1960s. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Prazepam is a prodrug for desmethyldiazepam which is responsible for the therapeutic effects of prazepam. Prazepam is indicated for the short-term treatment of anxiety. After short-term therapy, the dose is usually gradually tapered-off to reduce or avoid any withdrawal or rebound effects.


Catalog Number R032414
CAS Number 2955-38-6
Synonyms

7-Chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one; 1-(Cyclopropylmethyl)-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1-Cyclopropylmethyl-5-phenyl-7-chloro-1H-1,4-benzodiazepin-2(3H)-one; Centrax; Demetrin; K

Molecular Formula C19H17ClN2O
Purity ≥95%
Storage -20°C
IUPAC Name 7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one
InChI InChI=1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2
InChIKey MWQCHHACWWAQLJ-UHFFFAOYSA-N
SMILES C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4
Reference

</br>1: Sabia R, Ciogli A, Pierini M, Gasparrini F, Villani C. Dynamic high</br> performance liquid chromatography on chiral stationary phases. Low temperature</br> separation of the interconverting enantiomers of diazepam, flunitrazepam,</br> prazepam and tetrazepam. J Chromatogr A. 2014 Oct 10;1363:144-9. doi:</br> 10.1016/j.chroma.2014.07.097. Epub 2014 Aug 12. PubMed PMID: 25138707.</br>2: Ansseau M, Von Frenckell R. [Value of prazepam drops in the brief treatment of</br> anxiety disorders]. Encephale. 1991 Jul-Aug;17(4):291-4. French. PubMed PMID:</br> 1959497.</br>3: Dios-Vieitez MC, Renedo MJ, Fos D. Pharmacokinetic profiles of prazepam and</br> 14C-prazepam in rat. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:3-8. PubMed</br> PMID: 1820896.</br>4: Girre C, Hirschhorn M, Bertaux L, Palombo S, Fournier PE. Comparison of</br> performance of healthy volunteers given prazepam alone or combined with ethanol. </br> Relation to drug plasma concentrations. Int Clin Psychopharmacol. 1991</br> Winter;6(4):227-38. PubMed PMID: 1816280.</br>5: Girre C, Bertaux L, Dussaucy E, Bonnet D, Palombo S, Fournier PE. Comparison</br> of the effect of two prazepam formulations on psychomotor and cognitive function </br> in healthy volunteers. Int Clin Psychopharmacol. 1990 Jan;5(1):57-64. PubMed</br> PMID: 2332608.</br>6: Lu XL, Yang SK. Metabolism of prazepam by rat liver microsomes:</br> stereoselective formation and N-dealkylation of 3-hydroxyprazepam. Mol Pharmacol.</br> 1989 Dec;36(6):932-8. PubMed PMID: 2601688.</br>7: Greenblatt DJ, Harmatz JS, Dorsey C, Shader RI. Comparative single-dose</br> kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo. Clin</br> Pharmacol Ther. 1988 Sep;44(3):326-34. PubMed PMID: 3138056.</br>8: Manani G, Peretti S, Pagnacco A, Chiaranda M, Giron GP. [Sedation of the</br> ambulatory dental patient with diazepam and with prazepam. Double blind study]. G</br> Anest Stomatol. 1987 Jul-Sep;16(3):9-16. Italian. PubMed PMID: 3483357.</br>9: Hakuba A, Matysiakiewicz J. [The habit-forming effect of prazepam]. Psychiatr </br> Pol. 1986 May-Jun;20(3):232-4. Polish. PubMed PMID: 3797537.</br>10: Hüscher C, Magni G, Salmi A, Bossini S, Felini C, Besozzi F, de Leo D.</br> Ranitidine versus ranitidine and prazepam in the short-term treatment of duodenal</br> ulcer–a double-blind controlled trial. Eur J Clin Pharmacol. 1985;28(2):177-80. </br> PubMed PMID: 3886404.</br>11: Ochs HR, Greenblatt DJ, Verburg-Ochs B, Locniskar A. Comparative single-dose </br> kinetics of oxazolam, prazepam, and clorazepate: three precursors of</br> desmethyldiazepam. J Clin Pharmacol. 1984 Oct;24(10):446-51. PubMed PMID:</br> 6150943.</br>12: Shader RI, Pary RJ, Harmatz JS, Allison S, Locniskar A, Greenblatt DJ. Plasma</br> concentrations and clinical effects after single oral doses of prazepam,</br> clorazepate, and diazepam. J Clin Psychiatry. 1984 Oct;45(10):411-3. PubMed PMID:</br> 6148339.</br>13: Ansseau M, Doumont A, von Frenckell R, Collard J. Duration of benzodiazepine </br> clinical activity: lack of direct relationship with plasma half-life. A</br> comparison of single vs divided dosage schedules of prazepam. Psychopharmacology </br> (Berl). 1984;84(3):293-8. PubMed PMID: 6151206.</br>14: Köhler-Schmidt H, Bohn G. Radioimmunoassay for determination of prazepam and </br> its metabolites. Forensic Sci Int. 1983 Aug-Sep;22(2-3):243-8. PubMed PMID:</br> 6416955.</br>15: Blaha L. [The use of prazepam (mono demetrin) and bromazepam in general</br> psychovegetative disorders. A controlled multicenter field study]. Fortschr Med. </br> 1982 Nov 25;100(44):2075-80. German. PubMed PMID: 6129184.</br>16: Ikuta J, Yamauchi Y, Shimizu S. [Effect of prazepam on experimental</br> hypertensive models]. Nihon Yakurigaku Zasshi. 1982 Jun;79(6):581-9. Japanese.</br> PubMed PMID: 7129244.</br>17: Kölle EU. [Pharmacokinetics of oral prazepam]. Fortschr Med. 1981 Jun</br> 11;99(22):874-9. German. PubMed PMID: 6790396.</br>18: Delpierre S, Jammes Y, Grimaud C, Dugué P, Arnaud A, Charpin J. Influence of </br> anxiolytic drugs (Prazepam and Diazepam) on respiratory center output and CO2</br> chemosensitivity in patients with lung diseases. Respiration. 1981;42(1):15-20.</br> PubMed PMID: 6800003.</br>19: Klapetek J. [The tranquilizer Demetrin (prazepam)]. Cesk Neurol Neurochir.</br> 1980 Jan;43(1):51-8. Czech. PubMed PMID: 7357661.</br>20: Smith MT, Evans LE, Eadie MJ, Tyrer JH. Pharmacokinetics of prazepam in man. </br> Eur J Clin Pharmacol. 1979 Sep;16(2):141-7. PubMed PMID: 387419.</br></br>

Request a Quote